MT

Morphic Therapeutic

Waltham, United States · Founded 2015 · $414.0M raised

Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$414.0M
Last Round
$276.0M Series CMay 2023
Rounds
4

About

Morphic Therapeutic was a Waltham, Massachusetts-based biopharmaceutical company founded in 2014 by Timothy A. Springer of Harvard Medical School, focused on developing a new generation of small-molecule oral integrin therapies for immunological, fibrotic, neoplastic, and vascular diseases. The company built its platform on decades of integrin biology research and partnered with major pharmaceutical companies including AbbVie and Schrödinger. In July 2024, Eli Lilly acquired Morphic Therapeutic to expand its immunology pipeline with oral integrin therapies.

Summary

Morphic Therapeutic is a Biotech company based in Waltham, United States, founded in 2015. It has raised $414.0M in total across 4 rounds, most recently a $276.0M Series C round in May 2023. Investors include SR One, Pfizer Ventures and Omega Funds.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series CSeries CMay 2023
$276.0M

Sign up to see all 4 rounds

Seed through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Morphic Therapeutic on Indexed.vc
<a href="https://indexed.vc/companies/morphic-therapeutic"><img src="https://indexed.vc/api/badge/company/morphic-therapeutic" alt="Morphic Therapeutic on Indexed.vc" width="260" height="76" /></a>